Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Friesen

Showing results (261-270 of 281) with videos related to

Pageof 29
Sort By:
Molecular Cancer Therapeutics|July 29, 2003
Enhancement of platinum-induced cytotoxicity by O6-benzylguanineMelissa L Fishel, Shannon M Delaney, Lindsay D Friesen, et al.
Cancer Research|June 25, 2009
Insulin-like growth factor-II methylation status in lymphocyte DNA and colon cancer risk in the Northern Sweden Health and Disease cohortRudolf Kaaks, Pär Stattin, Stéphanie Villar, et al.
Expert Opinion on Investigational Drugs|November 1, 2005
MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injuryDavid E Kandzari, Jean-Pierre Dery, Paul W Armstrong, et al.
Cancer Letters|December 4, 2012
Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from ThailandSandra Ortiz-Cuaran, Stephanie Villar, Doriane Gouas, et al.
International Journal of Cancer|April 20, 2004
Ser-249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West AfricaKatarzyna Szymańska, Olufunmilayo A Lesi, Gregory D Kirk, et al.
Princess Takamatsu Symposia|January 1, 1995
Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesisF Kadlubar, R K Kaderlik, G J Mulder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2009
Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trialJeannette M Schenk, Elio Riboli, Nilanjan Chatterjee, et al.
Cancer Research|February 24, 2001
Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometryP E Jackson, G S Qian, M D Friesen, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Mind the gap: Understanding discordance between culture- and a non-culture-based measure of bacterial burden in murine tuberculosis treatment modelsSamuel T Tabor, Allan D Friesen, Matthew J Reichlen, et al.
Human Molecular Genetics|November 5, 1997
Identification and characterization of human genes encoding Hprp3p and Hprp4p, interacting components of the spliceosomeA Wang, J Forman-Kay, Y Luo, et al.
Pageof 29

Showing results (261-270 of 281) with videos related to

Sort By:
Pageof 29
Molecular Cancer Therapeutics|July 29, 2003
Enhancement of platinum-induced cytotoxicity by O6-benzylguanineMelissa L Fishel, Shannon M Delaney, Lindsay D Friesen, et al.
Cancer Research|June 25, 2009
Insulin-like growth factor-II methylation status in lymphocyte DNA and colon cancer risk in the Northern Sweden Health and Disease cohortRudolf Kaaks, Pär Stattin, Stéphanie Villar, et al.
Expert Opinion on Investigational Drugs|November 1, 2005
MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injuryDavid E Kandzari, Jean-Pierre Dery, Paul W Armstrong, et al.
Cancer Letters|December 4, 2012
Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from ThailandSandra Ortiz-Cuaran, Stephanie Villar, Doriane Gouas, et al.
International Journal of Cancer|April 20, 2004
Ser-249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West AfricaKatarzyna Szymańska, Olufunmilayo A Lesi, Gregory D Kirk, et al.
Princess Takamatsu Symposia|January 1, 1995
Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesisF Kadlubar, R K Kaderlik, G J Mulder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2009
Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trialJeannette M Schenk, Elio Riboli, Nilanjan Chatterjee, et al.
Cancer Research|February 24, 2001
Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometryP E Jackson, G S Qian, M D Friesen, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Mind the gap: Understanding discordance between culture- and a non-culture-based measure of bacterial burden in murine tuberculosis treatment modelsSamuel T Tabor, Allan D Friesen, Matthew J Reichlen, et al.
Human Molecular Genetics|November 5, 1997
Identification and characterization of human genes encoding Hprp3p and Hprp4p, interacting components of the spliceosomeA Wang, J Forman-Kay, Y Luo, et al.
Pageof 29